The hypoxia target adrenomedullin is aberrantly expressed in multiple myeloma and promotes angiogenesis.

Kocemba, K A; van Andel, H; de Haan-Kramer, A; Mahtouk, K; Versteeg, R; Kersten, M J; Spaargaren, M; Pals, S T

Kocemba, K A; van Andel, H; de Haan-Kramer, A; Mahtouk, K; Versteeg, R; Kersten, M J; Spaargaren, M; Pals, S T.

Affiliation

Kocemba KA; Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Leukemia ; 27(8): 1729-37, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23478664

Subject(s)

Adrenomedullin/genetics; Gene Expression Regulation, Neoplastic; Hypoxia/genetics; Multiple Myeloma/genetics; Multiple Myeloma/pathology; Neovascularization, Pathologic/genetics; Cell Line, Tumor; Disease Progression; Gene Expression Profiling; Humans; Hypoxia-Inducible Factor 1, alpha Subunit/genetics; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism; Multiple Myeloma/metabolism; NF-kappa B/genetics; NF-kappa B/metabolism; Transcription, Genetic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / Adrenomedullin / Hypoxia / Multiple Myeloma / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google